publication venue for
- A small molecule inhibitor of the perinucleolar compartment, ML246, attenuates growth and spread of ovarian cancer.. 5. 2018
- Clinical trial experience with CA4P anticancer therapy: focus on efficacy, cardiovascular adverse events, and hypertension management. 2018
- New therapies for advanced, recurrent, and metastatic endometrial cancers. 2017
- Homologous recombination deficiency (HRD) testing in ovarian cancer clinical practice: a review of the literature. 2017